These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16193322)

  • 1. Estimating utility data from clinical indicators for patients with stable angina.
    Longworth L; Buxton MJ; Sculpher M; Smith DH
    Eur J Health Econ; 2005 Dec; 6(4):347-53. PubMed ID: 16193322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting EQ-5D values using the SGRQ.
    Starkie HJ; Briggs AH; Chambers MG; Jones P
    Value Health; 2011; 14(2):354-60. PubMed ID: 21402304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
    Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
    Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the EQ-5D index and measures of clinical outcomes in selected studies of cardiovascular interventions.
    Goldsmith KA; Dyer MT; Schofield PM; Buxton MJ; Sharples LD
    Health Qual Life Outcomes; 2009 Nov; 7():96. PubMed ID: 19941657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of cost-utility ratios: results across five trial-based cost-utility studies.
    Joore M; Brunenberg D; Nelemans P; Wouters E; Kuijpers P; Honig A; Willems D; de Leeuw P; Severens J; Boonen A
    Value Health; 2010; 13(2):222-9. PubMed ID: 19878492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease.
    Goldsmith KA; Dyer MT; Buxton MJ; Sharples LD
    Health Qual Life Outcomes; 2010 Jun; 8():54. PubMed ID: 20525323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
    Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU
    Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life measured with EQ-5D in patients treated for depression in primary care.
    Sobocki P; Ekman M; Agren H; Krakau I; Runeson B; Mårtensson B; Jönsson B
    Value Health; 2007; 10(2):153-60. PubMed ID: 17391424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in patients with coronary artery disease treated for angina: validity and reliability of German translations of two specific questionnaires.
    Höfer S; Benzer W; Schüssler G; von Steinbüchel N; Oldridge NB
    Qual Life Res; 2003 Mar; 12(2):199-212. PubMed ID: 12639066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Italian population-based values of EQ-5D health states.
    Scalone L; Cortesi PA; Ciampichini R; Belisari A; D'Angiolella LS; Cesana G; Mantovani LG
    Value Health; 2013; 16(5):814-22. PubMed ID: 23947975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning.
    Günther OH; Roick C; Angermeyer MC; König HH
    J Affect Disord; 2008 Jan; 105(1-3):81-91. PubMed ID: 17532051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D.
    Sach TH; Barton GR; Doherty M; Muir KR; Jenkinson C; Avery AJ
    Int J Obes (Lond); 2007 Jan; 31(1):189-96. PubMed ID: 16682976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating EQ-5D values from the Neck Disability Index and numeric rating scales for neck and arm pain.
    Carreon LY; Bratcher KR; Das N; Nienhuis JB; Glassman SD
    J Neurosurg Spine; 2014 Sep; 21(3):394-9. PubMed ID: 24905392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores.
    Kay S; Ferreira A
    Ophthalmic Epidemiol; 2014 Apr; 21(2):66-78. PubMed ID: 24568628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team.
    Nease RF; Kneeland T; O'Connor GT; Sumner W; Lumpkins C; Shaw L; Pryor D; Sox HC
    JAMA; 1995 Apr; 273(15):1185-90. PubMed ID: 7707625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of physician-rated disease severity and patient reported outcomes in mild to moderately active ulcerative colitis.
    Poole CD; Connolly MP; Nielsen SK; Currie CJ; Marteau P
    J Crohns Colitis; 2010 Sep; 4(3):275-82. PubMed ID: 21122516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the EQ-5D measure quality of life in schizophrenia?
    Halling Hastrup L; Nordentoft M; Hjorthøj C; Gyrd-Hansen D
    J Ment Health Policy Econ; 2011 Dec; 14(4):187-96. PubMed ID: 22345360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial-based cost-utility comparison of percutaneous myocardial laser revascularisation and continued medical therapy for treatment of refractory angina pectoris.
    Campbell HE; Tait S; Sharples LD; Caine N; Gray TJ; Schofield PM; Buxton MJ
    Eur J Health Econ; 2005 Dec; 6(4):288-97. PubMed ID: 16195897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.